Значения термина recurrent hcc на английском

Conclusions: Aggressive management of recurrent HCC after upfront LR improves patient survival.

Conclusion: TACE combined with PEI may improve the survival of recurrent HCC patients.

However, early detection of recurrent HCC remains limited, particularly at the site of treated lesion.

Results: The authors identified 45 patients treated with bland embolization for recurrent HCC after resection.

Methods: The data of 130 surgically resected but recurrent HCC patients treated by TACE were reviewed retrospectively.

Conclusion: Palliative chemotherapy can be delivered to patients with recurrent HCC after liver transplantation with tolerable toxicity.

The numbers of treatment-naive and recurrent HCC patients were 1 and 10, respectively.

Our results might aid in identifying candidates for TACE for recurrent HCC, considering the major effect on patient outcomes.

Conclusions: Vascular invasion and time to recurrence were the prognostic factors for overall survival following second resection of intrahepatic recurrent HCC.

Prognosis is poor in recurrent HCC, a longer interval between OLT and recurrence and feasibility of surgical resection are associated with improved survival.

The purpose of the current study was to review the authors' experience using bland hepatic arterial embolization to treat recurrent HCC after definitive surgical resection.

Conclusion: Overall, this suggests that detection of HCC-associated DNA markers in urine could provide a promising tool to complement detection of recurrent HCC by imaging.